An open-label, rater-blinded, 8-week trial of bupropion hydrochloride extended-release in patients with major depressive disorder with atypical features.

Seo, H-J; Lee, B C; Seok, J-H; Jeon, H J; Paik, J-W; Kim, W; Kwak, K-P; Han, C; Lee, K-U; Pae, C-U

Seo, H-J; Lee, B C; Seok, J-H; Jeon, H J; Paik, J-W; Kim, W; Kwak, K-P; Han, C; Lee, K-U; Pae, C-U.

Affiliation

Seo HJ; Department of Psychiatry, The Catholic University of Korea College of Medicine, Seoul, Korea.

Pharmacopsychiatry ; 46(6): 221-6, 2013 Sep.

Article in En | MEDLINE | ID: mdl-23963965

Subject(s)

Antidepressive Agents, Second-Generation/therapeutic use; Bupropion/therapeutic use; Depressive Disorder, Major/drug therapy; Adult; Antidepressive Agents, Second-Generation/administration & dosage; Antidepressive Agents, Second-Generation/adverse effects; Bupropion/administration & dosage; Bupropion/adverse effects; Delayed-Action Preparations/adverse effects; Depressive Disorder, Major/diagnosis; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Single-Blind Method

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bupropion / Antidepressive Agents, Second-Generation / Depressive Disorder, Major Type of study: Clinical_trials / Diagnostic_studies / Qualitative_research Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Pharmacopsychiatry Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google